Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.33967 | 53 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.2363 | 51 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.23635 | 51 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.12423 | 50 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.17361 | 51 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.40256 | 53 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.45369 | 55 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.27904 | 53 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.19252 | 50 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.19514 | 50 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.2384 | 51 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.13353 | 49 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.45111 | 57 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.23664 | 51 |